| Статус: | Completed |
| Фаза: | Phase 3 |
| Начало: | 1 января 2016 г. |
| Окончание: | 1 мая 2016 г. |
| Описание: | The purpose of this study is to determine whether Ingavirin ® dosed 30 mg daily is effective and safe in the treatment of influenza and other acute respiratory viral infections in the course of standard therapy in 3-6 years old patients. |
| смотреть на ClinicalTrials.gov |